Case-control Study and Meta-analysis of SULT1A1 Arg213His Polymorphism for Gene, Ethnicity and Environment Interaction for Cancer Risk

Overview

Journal Br J Cancer

Specialty Oncology

Date 2008 Oct 16

PMID 18854828

Citations 16

Authors

A Kotnis

S Kannan

R Sarin

R Mulherkar

Affiliations

Soon will be listed here.

Abstract

Cytosolic sulphotransferase SULT1A1 plays a dual role in the activation of some carcinogens and inactivation of others. A functional polymorphism leading to Arg(213)His substitution (SULT1A1*2) affects its catalytic activity and thermostability. To study the association of SULT1A1*2 polymorphism with tobacco-related cancers (TRCs), a case-control study comprising 132 patients with multiple primary neoplasm (MPN) involving TRC and 198 cancer-free controls was carried out. One hundred and thirteen MPN patients had at least one cancer in upper aerodigestive tract including lung (UADT-MPN). SULT1A1*2 showed significant risk association with UADT-MPN (odds ratio (OR)=5.50, 95% confidence interval (CI): 1.09, 27.7). Meta-analysis was conducted combining the data with 34 published studies that included 11 962 cancer cases and 14 673 controls in diverse cancers. The SULT1A1*2 revealed contrasting risk association for UADT cancers (OR=1.62, 95% CI: 1.12, 2.34) and genitourinary cancers (OR=0.73, 95% CI: 0.58, 0.92). Furthermore, although SULT1A1*2 conferred significant increased risk of breast cancer to Asian women (OR=1.91, 95% CI: 1.08, 3.40), it did not confer increased risk to Caucasian women (OR=0.92, 95% CI: 0.71, 1.18). Thus risk for different cancers in distinct ethnic groups could be modulated by interaction between genetic variants and different endogenous and exogenous carcinogens.

Citing Articles

Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.

Hakkaart C, Pearson J, Marquart L, Dennis J, Wiggins G, Barnes D Commun Biol. 2022; 5(1):1061.

PMID: 36203093 PMC: 9537519. DOI: 10.1038/s42003-022-03978-6.

Mediastinal thymoma in a patient with previous rectal and breast cancers: A report of a case with multiple primary cancers and review of literature.

Mardani P, Fallahi M, Kamran H, Shahriarirad R, Anbardar M, Soleimani N Clin Case Rep. 2022; 10(6):e5987.

PMID: 35769240 PMC: 9210131. DOI: 10.1002/ccr3.5987.

A review on the genetic polymorphisms and susceptibility of cancer patients in Bangladesh.

Babu G, Bin Islam S, Khan M Mol Biol Rep. 2022; 49(7):6725-6739.

PMID: 35277785 DOI: 10.1007/s11033-022-07282-8.

Correlation between prostate stem cell antigen gene expression and oral squamous cell carcinoma.

Zhao K, Li X, Wang J, Liu J, Gong W, Xu H Oncol Lett. 2018; 15(6):9151-9161.

PMID: 29844822 PMC: 5958807. DOI: 10.3892/ol.2018.8468.

Relationship of SULT1A1 copy number variation with estrogen metabolism and human health.

Liu J, Zhao R, Ye Z, Frey A, Schriver E, Snyder N J Steroid Biochem Mol Biol. 2017; 174:169-175.

PMID: 28867356 PMC: 5675753. DOI: 10.1016/j.jsbmb.2017.08.017.

References

Hung R, Boffetta P, Brennan P, Malaveille C, Hautefeuille A, Donato F . GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer. 2004; 110(4):598-604. DOI: 10.1002/ijc.20157. View

Meinl W, Pabel U, Osterloh-Quiroz M, Hengstler J, Glatt H . Human sulphotransferases are involved in the activation of aristolochic acids and are expressed in renal target tissue. Int J Cancer. 2005; 118(5):1090-7. DOI: 10.1002/ijc.21480. View

Carlsten C, Sagoo G, Frodsham A, Burke W, Higgins J . Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol. 2008; 167(7):759-74. DOI: 10.1093/aje/kwm383. View

Steiner M, Bastian M, Schulz W, Pulte T, Franke K, Rohring A . Phenol sulphotransferase SULT1A1 polymorphism in prostate cancer: lack of association. Arch Toxicol. 2000; 74(4-5):222-5. DOI: 10.1007/s002040000118. View

Mikhailova O, Gulyaeva L, Prudnikov A, Gerasimov A, Krasilnikov S . Estrogen-metabolizing gene polymorphisms in the assessment of female hormone-dependent cancer risk. Pharmacogenomics J. 2006; 6(3):189-93. DOI: 10.1038/sj.tpj.6500365. View

Tang D, Rundle A, Mooney L, Cho S, Schnabel F, Estabrook A . Sulfotransferase 1A1 (SULT1A1) polymorphism, PAH-DNA adduct levels in breast tissue and breast cancer risk in a case-control study. Breast Cancer Res Treat. 2003; 78(2):217-22. DOI: 10.1023/a:1022968303118. View

Hong W, Lippman S, Itri L, Karp D, Lee J, Byers R . Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med. 1990; 323(12):795-801. DOI: 10.1056/NEJM199009203231205. View

Nowell S, Sweeney C, Winters M, Stone A, Lang N, Hutchins L . Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy. J Natl Cancer Inst. 2002; 94(21):1635-40. DOI: 10.1093/jnci/94.21.1635. View

Moreno V, Glatt H, Guino E, Fisher E, Meinl W, Navarro M . Polymorphisms in sulfotransferases SULT1A1 and SULT1A2 are not related to colorectal cancer. Int J Cancer. 2004; 113(4):683-6. DOI: 10.1002/ijc.20613. View

10.

Jhavar S, Sarin R, Chopra S, Kotnis A, Mulherkar R, AHern R . Females with paired occurrence of cancers in the UADT and genital region have a higher frequency of either Glutathione S-transferase M1/T1 null genotype. J Carcinog. 2005; 4(1):6. PMC: 1079904. DOI: 10.1186/1477-3163-4-6. View

11.

Tsukino H, Kuroda Y, Nakao H, Imai H, Inatomi H, Osada Y . Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer. J Cancer Res Clin Oncol. 2003; 130(2):99-106. DOI: 10.1007/s00432-003-0512-0. View

12.

Cheng T, Chen S, Huang C, Fu Y, Yu J, Cheng C . Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility. Int J Cancer. 2004; 113(3):345-53. DOI: 10.1002/ijc.20630. View

13.

Hildebrandt M, Carrington D, Thomae B, Eckloff B, Schaid D, Yee V . Genetic diversity and function in the human cytosolic sulfotransferases. Pharmacogenomics J. 2006; 7(2):133-43. DOI: 10.1038/sj.tpj.6500404. View

14.

Han D, Zhou X, Hu M, Xie W, Mao Z, Chen D . Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study. Chin Med J (Engl). 2005; 118(18):1507-16. View

15.

Nowell S, Ahn J, Rae J, Scheys J, Trovato A, Sweeney C . Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients. Breast Cancer Res Treat. 2005; 91(3):249-58. DOI: 10.1007/s10549-004-7751-x. View

16.

Nowell S, Coles B, Sinha R, MacLeod S, Ratnasinghe D, Stotts C . Analysis of total meat intake and exposure to individual heterocyclic amines in a case-control study of colorectal cancer: contribution of metabolic variation to risk. Mutat Res. 2002; 506-507:175-85. DOI: 10.1016/s0027-5107(02)00164-1. View

17.

Wu M, Wang Y, Ho C, Wu D, Lee Y, Hsu H . SULT1A1 polymorphism and esophageal cancer in males. Int J Cancer. 2002; 103(1):101-4. DOI: 10.1002/ijc.10805. View

18.

Choi J, Lee K, Park S, Noh D, Ahn S, Chung H . Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer. Cancer Epidemiol Biomarkers Prev. 2005; 14(5):1090-5. DOI: 10.1158/1055-9965.EPI-04-0688. View

19.

Cheng L, Sturgis E, Eicher S, Char D, Spitz M, Wei Q . Glutathione-S-transferase polymorphisms and risk of squamous-cell carcinoma of the head and neck. Int J Cancer. 1999; 84(3):220-4. DOI: 10.1002/(sici)1097-0215(19990621)84:3<220::aid-ijc4>3.0.co;2-s. View

20.

Sellers T, Schildkraut J, Pankratz V, Vierkant R, Fredericksen Z, Olson J . Estrogen bioactivation, genetic polymorphisms, and ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2005; 14(11 Pt 1):2536-43. DOI: 10.1158/1055-9965.EPI-05-0142. View